SCHEMBL17825259

SCHEMBL17825259

CC1(NS(=O)(=O)c2ccc3[nH]c(=O)n(Cc4cc(NC(=O)OC(C)(C)C)no4)c(=O)c3c2)CC1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17825051 0.85 PARG (0.72) PARG
SCHEMBL17824786 0.83 PARG (1.00) PARG
SCHEMBL17825032 0.79 PARG (0.76) PARG
SCHEMBL17825161 0.76 PARG (0.73) PARG
SCHEMBL17825140 0.75 PARG (1.00) PARG
SCHEMBL17824704 0.74 PARG (1.00) PARG
SCHEMBL17825111 0.73 PARG (0.80) PARG
SCHEMBL17825285 0.73 PARG (0.42) PARG
SCHEMBL17825175 0.73 PARG (1.00) PARG
SCHEMBL17824885 0.72 PARG (1.00) PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230273-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG Cancer Research Technology Ltd (GB) 2017-10-18 EP disclosed
WO-2016092326-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-16 WO disclosed